Kings Point Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$214K Hold
435
0.02% 196
2021
Q4
$202K Hold
435
0.02% 224
2021
Q3
$162K Buy
435
+100
+30% +$38K 0.01% 223
2021
Q2
$128K Hold
335
0.01% 243
2021
Q1
$120K Buy
+335
New +$108K 0.01% 242
2016
Q3
Sell
-92
Closed -$12K 315
2016
Q2
$12K Hold
92
﹤0.01% 308
2016
Q1
$13K Hold
92
﹤0.01% 302
2015
Q4
$13K Buy
+92
New +$12.7K ﹤0.01% 333

Other funds holding ELV

Kings Point Capital Management's ELV Position: Q1 2022 in Review

Kings Point Capital Management held its Elevance Health (ELV) position steady in Q1 2022 at 435 shares worth $214K. The position accounts for 0.02% of the portfolio, ranked #196.

Kings Point Capital Management first reported a position in ELV in Q4 2015 and has held it in 8 quarters since. 1,418 funds tracked by Wall St. Rank hold ELV as of Q1 2022.

  • Kings Point Capital Management held 435 shares of Elevance Health worth $214K as of Q1 2022.
  • Kings Point Capital Management left its Elevance Health share count unchanged in Q1 2022.
  • Elevance Health made up 0.02% of Kings Point Capital Management's portfolio in Q1 2022, its #196 holding.
  • Kings Point Capital Management first reported a position in Elevance Health in Q4 2015 and has held it in 8 quarters since.
  • 1,418 funds tracked by Wall St. Rank held Elevance Health as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.